Apigenin analogues as SARS-CoV-2 main protease inhibitors: In-silico screening approach

The COVID-19 new variants spread rapidly all over the world, and until now scientists strive to find virus-specific antivirals for its treatment. The main protease of SARS-CoV-2 (M(pro)) exhibits high structural and sequence homology to main protease of SARS-CoV (93.23% sequence identity), and their...

Descripción completa

Detalles Bibliográficos
Autores principales: Farhat, Ameny, Ben Hlima, Hajer, Khemakhem, Bassem, Ben Halima, Youssef, Michaud, Philippe, Abdelkafi, Slim, Fendri, Imen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974217/
https://www.ncbi.nlm.nih.gov/pubmed/35048792
http://dx.doi.org/10.1080/21655979.2022.2027181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974217/
https://www.ncbi.nlm.nih.gov/pubmed/35048792
http://dx.doi.org/10.1080/21655979.2022.2027181

Ejemplares similares